These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 14566858)

  • 1. Metastasis of benign tumor cells in tuberous sclerosis complex.
    Henske EP
    Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
    Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
    J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.
    Strizheva GD; Carsillo T; Kruger WD; Sullivan EJ; Ryu JH; Henske EP
    Am J Respir Crit Care Med; 2001 Jan; 163(1):253-8. PubMed ID: 11208653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
    Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
    Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary lymphangioleiomyomatosis in tuberous sclerosis. A case report.
    De Rosa N
    Pathologica; 2009 Oct; 101(5):186-9. PubMed ID: 20218060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges.
    Goncharova EA; Krymskaya VP
    J Cell Biochem; 2008 Feb; 103(2):369-82. PubMed ID: 17541983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
    Plank TL; Logginidou H; Klein-Szanto A; Henske EP
    Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
    Yu J; Astrinidis A; Henske EP
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.
    Sato T; Seyama K; Kumasaka T; Fujii H; Setoguchi Y; Shirai T; Tomino Y; Hino O; Fukuchi Y
    J Intern Med; 2004 Aug; 256(2):166-73. PubMed ID: 15257730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.
    Carsillo T; Astrinidis A; Henske EP
    Proc Natl Acad Sci U S A; 2000 May; 97(11):6085-90. PubMed ID: 10823953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
    Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
    Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteins interacting with the tuberous sclerosis gene products.
    Rosner M; Freilinger A; Hengstschläger M
    Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociate expression of tuberous sclerosis complex 1 product hamartin in a skin and pulmonary lesion of a tuberous sclerosis complex.
    Wataya-Kaneda M; Katayama I
    Hum Pathol; 2009 Mar; 40(3):430-4. PubMed ID: 18835623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.
    Karbowniczek M; Astrinidis A; Balsara BR; Testa JR; Lium JH; Colby TV; McCormack FX; Henske EP
    Am J Respir Crit Care Med; 2003 Apr; 167(7):976-82. PubMed ID: 12411287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberous sclerosis and lymphangioleiomyomatosis.
    Noonan DJ; Lou D; Griffith N; Vanaman TC
    Arch Biochem Biophys; 2002 Feb; 398(1):132-40. PubMed ID: 11811958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphangioleiomyomatosis: A review.
    Hohman DW; Noghrehkar D; Ratnayake S
    Eur J Intern Med; 2008 Jul; 19(5):319-24. PubMed ID: 18549932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.